APC and lung cancer: Given that β-catenin and APC mutation is less commonly observed in lung cancer than in other cancer types such as colon cancer, understanding the mechanism by which these Wnt signaling inhibitors regulate the β-catenin destruction complex is crucial (Stewart, 2014).